<!DOCTYPE html><html prefix="og: http://ogp.me/ns#" lang="zh">
<!-- Mirrored from cn.nytimes.com/business/20201230/china-coronavirus-vaccine/zh-hant/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:11:32 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head><meta charset="UTF-8"><!-- Browser render  --><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="renderer" content="webkit"><!-- End Browser render --><meta name="keywords" content=""><meta name="description" content="中國政府計劃在春節前為5000萬人接種新冠疫苗。各地已準備好接種、存儲等配套設施，但目前尚無大量證明國產疫苗有效的證據，監管機構也沒有正式批准疫苗上市。"><meta id="uuid" name="uuid" content="0e32fb4b63183c78e878a0da2ba66374"><meta id="headline" name="headline" content="中國的新冠疫苗接種運動：萬事俱備，還差什麼？ - 紐約時報中文網"><meta id="byline" name="byline" content="黃瑞黎"><meta id="date" name="date" content="2020-12-30T02:50:47.000Z"><link rel="alternate" href="../../index.html" hreflang="zh-Hans"><link rel="alternate" href="../index.html" hreflang="zh-Hant"><link rel="alternate" href="https://www.nytimes.com/2020/12/29/business/china-coronavirus-vaccine.html" hreflang="en-us"><link rel="canonical" href="../index.html"><link rel="alternate" type="application/rss+xml" href="https://cn.nytimes.com/rss/zh-hant/"><meta name="apple-itunes-app" content="app-id=807498298, app-argument=nytimescn://article:0e32fb4b63183c78e878a0da2ba66374"><meta name="lang" property="lang" content="zh-cmn-hant"><!-- Apple IOS safari private meta --><link rel="apple-touch-icon-precomposed" sizes="144×144" href="../../../../../../static01.nyt.com/images/icons/ios-ipad-144x144.png"><link rel="apple-touch-icon-precomposed" sizes="114×114" href="../../../../../../static01.nyt.com/images/icons/ios-iphone-114x144.png"><link rel="apple-touch-icon-precomposed" href="../../../../../../static01.nyt.com/images/icons/ios-default-homescreen-57x57.png"><meta name="apple-mobile-web-app-title" content="中國的新冠疫苗接種運動：萬事俱備，還差什麼？ - 紐約時報中文網"><meta name="apple-mobile-web-app-capable" content="yes"><!-- End Apple IOS safari private meta --><!-- Viewport and mobile --><meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no,maximum-scale=1,minimum-scale=1,minimal-ui"><!-- End viewport and mobile --><meta http-equiv="Cache-Control" content="no-siteapp"><meta name="format-detection" content="telephone=no"><meta name="HandheldFriendly" content="true"><meta name="MobileOptimized" content="320"><meta name="x5-orientation" content="portrait"><meta name="full-screen" content="yes"><meta name="x5-fullscreen" content="true"><meta name="browsermode" content="application"><meta name="x5-page-mode" content="app"><meta name="msapplication-tap-highlight" content="no"><meta property="og:title" content="中國的新冠疫苗接種運動：萬事俱備，還差什麼？"><meta property="og:type" content="article"><meta property="og:url" content="../index.html"><meta property="og:description" content="中國政府計劃在春節前為5000萬人接種新冠疫苗。各地已準備好接種、存儲等配套設施，但目前尚無大量證明國產疫苗有效的證據，監管機構也沒有正式批准疫苗上市。"><meta property="og:site_name" content="紐約時報中文網"><meta property="article:publisher" content="https://www.facebook.com/nytimeschinese"><meta property="article:published_time" content="2020-12-30T02:50:47.000Z"><meta property="fb:pages" content="1504603339831430"><meta property="fb:app_id" content="853699254762608"><meta property="og:image" content="../../../../../../static01.nyt.com/images/2020/12/28/business/00china-vaccine-3/00china-vaccine-3-articleLarge.html"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:url" content="../index.html"><meta property="twitter:title" content="中國的新冠疫苗接種運動：萬事俱備，還差什麼？"><meta property="twitter:description" content="中國政府計劃在春節前為5000萬人接種新冠疫苗。各地已準備好接種、存儲等配套設施，但目前尚無大量證明國產疫苗有效的證據，監管機構也沒有正式批准疫苗上市。"><meta property="twitter:domain" content="cn.nytimes.com"><meta property="twitter:site" content="@nytchinese"><meta property="twitter:creator" content="@nytchinese"><meta property="twitter:image:src" content="../../../../../../static01.nyt.com/images/2020/12/28/business/00china-vaccine-3/00china-vaccine-3-articleLarge.html"><meta name="PT" content="article"><meta name="PST" content="News"><meta name="CG" content="business"><meta name="SCG" content=""><meta name="sourceApp" content="nyt-china-web"><meta name="ptime" content="20201230024019"><meta name="utime" content="20201230025047"><meta name="pdate" content="20201230"><meta name="dat" content="Dec. 30, 2020"><meta name="hdl" content="中國的新冠疫苗接種運動：萬事俱備，還差什麼？"><meta name="byl" content="黃瑞黎"><meta name="lp" content="中國政府計劃在春節前為5000萬人接種新冠疫苗。各地已準備好接種、存儲等配套設施，但目前尚無大量證明國產疫苗有效的證據，監管機構也沒有正式批准疫苗上市。"><link rel="shortcut icon" href="https://static01.nyt.com/favicon.ico"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/style-flex.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/web/style.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/article.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/slideshow/slideshow.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/cookie-banner/style.min619b.css?v=f1810d8"><title>中國的新冠疫苗接種運動：萬事俱備，還差什麼？ - 紐約時報中文網</title></head><script>var js_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/js";
 var imgs_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style/imgs";
 var style_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style";
 var site = 1;
 var sectionName = "business";
 var adTyp = "art";
 var cookieString = {
     "title": "您的追蹤器設置",
     "headline": "我們使用 cookie 做什麼？",
     "summary": '<p>我們利用cookies和類似的技術識別您的重複訪問和偏好。我們還使用它們來衡量廣告系列的效果，定位廣告並分析和網站流量。更多關於cookies的資訊（包括如何停用），<a href="https://www.nytimes.com/zh-hant/privacy/cookie-policy" rel="noreferrer noopener" target="_blank" data-testid="GDPR-policy">請查看我們的「Cookie政策」</a>。</span><span>自2020年7月20日起，我們將根據您在我們服務中所訪問的內容類型向您顯示我們認為與您的興趣相關的廣告。您可以<a href="https://www.nytimes.com/zh-hant/privacy/cookie-policy#how-do-i-manage-trackers" rel="noreferrer noopener" target="_blank" data-testid="GDPR-objection">提出反對</a>。希望了解更多信息，請參見我們的<a href="https://nytimes.com/zh-hant/privacy/privacy-policy#we-allow-for-personalized-advertising-on-times-services" rel="noreferrer noopener" target="_blank" data-testid="GDPR-privacy">隱私政策</a>。</p><p>透過在此處點擊「我接受」或者「X」， 您將被視為同意使用cookies。您隨時可以通過我們的Cookie政策來更改您的跟踪器偏好。</p>',
     "button": "接受",
     "trackerButton": "您的追蹤器設置",
     "rejectButton": "拒絕所有",
     "lang": 'zh-hant',
     "trackerLink": "https://www.nytimes.com/zh-hant/privacy/cookie-policy",
 };
 var purrString = {
     "button": "請勿出售我的個人資訊",
     "snackbar": "你的設定已經保存在此瀏覽器和設備上。如果你清除了 cookie，這些設定也會被清除。",
     "snackbarError": "Something went wrong",
     "optedOutText": "我们不再出售您的個人資訊",
     "CFALinkText": "California Notices",
     "purrPopupTitle": "Your request to not sell your data will be stored for this browser and device",
     "purrPopupSummary": "If you clear your cookies, your preference will be forgotten. As a California resident, you have additional rights under the California Consumer Privacy Act of 2018. While The New York Times Company does not “sell” personal information of its readers as the term “sell” is traditionally understood, “sell” under the CCPA is broadly defined. To learn more, review the text below.",
     "purrPopupButton": "DISMISS",
     "purrPopupScrollContent": 'ssa sed. Nec sagittis aliquam malesuada bibendum arcu. Nunc sed blandit libero volutpat sed cras ornare arcu. Metus vulputate eu scelerisque felis imperdiet proin. Elit eget gravida cum sociis natoque penatibus. Sodales ut eu sem integer. Vitae auctor eu augue ut lectus arcu bibendum at. Vulputate ut pharetra sit amet aliquam id diam. Eu tincidunt tortor aliquam nulla facilisi cras fermentum odio eu. Imperdiet dui accumsan sit amet nulla facilisi morbi. Laoreet non curabitur gravida arcu ac tortor dignissim. Magna fringilla urna porttitor rhoncus dolor purus. In nulla posuere sollicitudin aliquam. At elementum eu facilisis sed odio. Diam in arcu cursus euismod quis viverra. Viverra suspendisse potenti nullam ac tortor vitae purus. Felis donec et odio pellentesque diam volutpat. Lacus sed turpis tincidunt id aliquet risus feugiat in.Aliquam ut porttitor leo a diam sollicitudin tempor',
     "lang": 'zh-hant'
 };
 cbSectionName = "business";
 cbByline = "黃瑞黎";</script><!-- Google Tag Manager --><script>(function(w,d,s,l,i){
     w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});
     var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
     j.async=true;j.src='../../../../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;
     f.parentNode.insertBefore(j,f);
 })(window,document,'script','dataLayer','GTM-KTDZV8V');</script><!-- End Google Tag Manager --><!-- chartbeat --><script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script><!-- /chartbeat --><body class="news"><main class="container-fluid main clearfix"><header class="row title-bar"><div class="nav-button default" id="menuBtn"><i class="icon-bars"></i></div><h1 class="logo"><a href="/"><svg role="img" aria-label="" width="90%" height="90%"><image width="100%" height="100%" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hant.svg" src="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hant%402x.png" alt="" border="0"></image></svg></a></h1><div class="nav-button default" id="gearBtn"><i class="icon-gear"></i></div><div class="popup gear-popup"><div class="tips-container"><div class="tips-border"></div><div class="tips-inner"></div></div><div class="popup-container"><div class="popup-body"><div class="setting-title">簡繁中文</div><div class="setting-option"><a href="../../index024e.html?changeLang=zh-hans">簡體 </a><a href="../../index27d8.html?changeLang=zh-hant" class="active">繁體</a></div><div class="setting-title">紐約時報 出版語言</div><ul class="menu-list"><li><a href="https://www.nytimes.com/">ENGLISH (英語)</a></li><li><a href="https://www.nytimes.com/es/">ESPAÑOL (西班牙語)</a></li></ul><div class="setting-title">字體大小</div><div class="setting-option"><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="small"> 小</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="normal" checked="checked"> 中</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="large"> 大</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="xlarge"> 超大</label></div></div></div></div></div></header><div class="top_banner_ad" id="topad" data-target="{&quot;pos&quot;:&quot;top&quot;,&quot;adv&quot;:&quot;&quot;}"></div><div class="article-area"><div class="setting-bar row"><div class="col-4 section-title"><h3>商業與經濟</h3></div><div class="col-8 setting-btns"><div class="row"><div class="col-6"><ul class="dual-btn"><li><a href="../../index.html"><span class="setting-btn-text">中文</span> <span class="setting-btn-text-mobile">中</span></a></li><li><a href="javascript:;" class="active"><span class="setting-btn-text">中英雙語</span> <span class="setting-btn-text-mobile">雙語</span></a></li><li><a href="https://www.nytimes.com/2020/12/29/business/china-coronavirus-vaccine.html" target="_blank"><span class="setting-btn-text">英文 <i class="icon-share-square"></i> </span><span class="setting-btn-text-mobile">英</span></a></li></ul></div><div class="col-6 share-tools-top-container"><ul class="share-tools mobile-article"><li><a href="http://v.t.sina.com.cn/share/share.php?&amp;title=%E4%B8%AD%E5%9C%8B%E7%9A%84%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E6%8E%A5%E7%A8%AE%E9%81%8B%E5%8B%95%EF%BC%9A%E8%90%AC%E4%BA%8B%E4%BF%B1%E5%82%99%EF%BC%8C%E9%82%84%E5%B7%AE%E4%BB%80%E9%BA%BC%EF%BC%9F&amp;url=https://cn.nytimes.com/business/20201230/china-coronavirus-vaccine/zh-hant/" target="_blank"><i class="icon-weibo"></i></a></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20201230/china-coronavirus-vaccine/zh-hant/" data-headline="%E4%B8%AD%E5%9C%8B%E7%9A%84%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E6%8E%A5%E7%A8%AE%E9%81%8B%E5%8B%95%EF%BC%9A%E8%90%AC%E4%BA%8B%E4%BF%B1%E5%82%99%EF%BC%8C%E9%82%84%E5%B7%AE%E4%BB%80%E9%BA%BC%EF%BC%9F"> --><!-- <i class="icon-wechat"></i> --><!-- </a> --><!-- </li> --><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://cn.nytimes.com/business/20201230/china-coronavirus-vaccine/zh-hant/" trage="_blank"><i class="icon-facebook"></i></a></li><li><a href="https://plus.google.com/share?url=https://cn.nytimes.com/business/20201230/china-coronavirus-vaccine/zh-hant/" target="_blank"><i class="icon-google"></i></a></li><li><a href="https://twitter.com/share?text=%E4%B8%AD%E5%9C%8B%E7%9A%84%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E6%8E%A5%E7%A8%AE%E9%81%8B%E5%8B%95%EF%BC%9A%E8%90%AC%E4%BA%8B%E4%BF%B1%E5%82%99%EF%BC%8C%E9%82%84%E5%B7%AE%E4%BB%80%E9%BA%BC%EF%BC%9F&amp;url=https://cn.nytimes.com/business/20201230/china-coronavirus-vaccine/zh-hant/" target="_blank"><i class="icon-twitter"></i></a></li><li><div class="line-it-button" data-lang="zh_Hant" data-type="share-g" data-url="https://cn.nytimes.com/business/20201230/china-coronavirus-vaccine/zh-hant/" style="display: none;"></div><script src="../../../../../../d.line-scdn.net/r/web/social-plugin/js/thirdparty/loader.min.js" async="async" defer="defer"></script></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20201230/china-coronavirus-vaccine/zh-hant/" data-headline="%E4%B8%AD%E5%9C%8B%E7%9A%84%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E6%8E%A5%E7%A8%AE%E9%81%8B%E5%8B%95%EF%BC%9A%E8%90%AC%E4%BA%8B%E4%BF%B1%E5%82%99%EF%BC%8C%E9%82%84%E5%B7%AE%E4%BB%80%E9%BA%BC%EF%BC%9F"> --><!-- <i class="icon-qrcode"></i> --><!-- </a> --><!-- </li> --></ul><div class="share-btn"><i class="icon-forward"></i></div></div></div></div></div><article class="article-content article-dual font-normal"><div class="article-header"><header><small></small><h1>中國的新冠疫苗接種運動：萬事俱備，還差什麼？</h1><h1 class="en-title">China Has All It Needs to Vaccinate Millions, Except Any Approved Vaccines</h1></header><div class="byline-row"><div class="byline-box"><div class="byline"><address>黃瑞黎</address><time pudate="2020-12-30 02:50:47" datetime="2020-12-30 02:50:47">2020年12月30日</time></div><div class="share-btn"><i class="icon-forward"></i></div></div></div></div><figure class="article-span-photo"><img src="../../../../../../static01.nyt.com/images/2020/12/28/business/00china-vaccine-3/00china-vaccine-3-master1050.html" width="1050" height="699" alt="位於北京的私營疫苗生產商科興生產了數以百萬計的疫苗，但還未獲得政府批准。"><figcaption><span>位於北京的私營疫苗生產商科興生產了數以百萬計的疫苗，但還未獲得政府批准。</span> <cite>Thomas Peter/Reuters</cite></figcaption></figure><div class="row"><section class="article-body"><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Hospitals all over China have almost everything necessary for a mass coronavirus vaccination drive: Millions of doses. Refrigerators to store them. Health care workers trained to administer them.</div></div><div class="col-lg-6"><div class="article-paragraph">中國各地的醫院幾乎具備大規模新冠疫苗接種行動所需的一切條件：數以百萬計的疫苗。可以儲存疫苗的冷櫃。受過接種培訓的醫務工作者。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Everything, that is, except much proof that their vaccines work.</div></div><div class="col-lg-6"><div class="article-paragraph">也就是說，除了大量證明其疫苗有效的證據之外，什麼都不缺。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Unlike their Western competitors, the Chinese companies <a href="https://www.nytimes.com/2020/11/17/business/china-coronavirus-vaccine-safety.html" title="Link: https://www.nytimes.com/2020/11/17/business/china-coronavirus-vaccine-safety.html">have not disclosed data from late-stage clinical trials</a> that would show whether their vaccines are effective, just one, the state-owned Sinopharm, has released findings, which it did on Wednesday. Regulators in China have not officially approved any of them.</div></div><div class="col-lg-6"><div class="article-paragraph">與西方競爭對手不同，中國企業沒有披露其疫苗是否有效的<a href="#https://cn.nytimes.com/china/20201118/china-coronavirus-vaccine-safety/">後期臨床試驗數據</a>，只有一款疫苗例外。國有的國藥集團週三公布了研究成果。中國監管機構還沒有正式批准這些疫苗。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">That has not deterred local governments across the country, which have begun an ambitious vaccination campaign. The goal is to inoculate 50 million people — roughly the population of Colombia — by the middle of February, before the Lunar New Year holiday, when hundreds of millions of people are expected to travel.<br></div></div><div class="col-lg-6"><div class="article-paragraph">但這並沒有阻止全國各地方政府，他們已經開始了一場雄心勃勃的疫苗接種行動。目標是在2月中旬，也就是春節假期之前為5000萬人——約等於哥倫比亞的人口——接種疫苗，屆時預計將有數億人出行。</div></div></div></div><div class="article-body-aside col-lg-3"><div id="subscribe_cont" style="margin: 0 auto;" class="container"></div></div></div><div class="big_ad" id="medium-rectangle-ad-0" data-target="{&quot;pos&quot;:&quot;mid1&quot;,&quot;adv&quot;:&quot;&quot;}"><small>廣告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">China, <a href="https://www.nytimes.com/2020/01/06/world/asia/china-SARS-pneumonialike.html">where the virus first emerged a year ago,</a> is going to great — and scientifically unorthodox — lengths to prevent a resurgence of the outbreak. While Beijing has not officially announced the vaccine target, the government has signaled the rollout will be managed in much the same way as the outbreak, through a top-down approach that can mobilize thousands of workers to produce, ship and administer the shots. Local officials were told that the drive was a “political mission.”</div></div><div class="col-lg-6"><div class="article-paragraph"><a href="#https://cn.nytimes.com/china/20200107/china-sars-pneumonialike/">作為一年前病毒首次出現的地方</a>，中國正在竭盡全力——並以科學上非正統的方式——防止疫情再度暴發。雖然北京還沒有正式宣布疫苗接種目標，但政府已經表示，將以同防控疫情大致相同的方式管理疫苗的分發，自上而下地動員成千上萬的工人進行生產、運輸和管理。地方官員被告知，此行動是一項「政治任務」。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The campaign will focus on what China calls “key priority groups,” including doctors, hotel employees, border inspection personnel, food storage and transportation workers, as well as travelers. Irene Zhang, a 24-year-old student, got a vaccine on Dec. 22 in the city of Hangzhou ahead of going to Britain next month for graduate school.</div></div><div class="col-lg-6"><div class="article-paragraph">這項行動將主要關注中國所稱的「重點優先人群」，包括醫生、酒店員工、邊防檢查人員、食品儲存和運輸工人以及旅客。24歲的學生艾琳·張（Irene Zhang，音）於12月22日在杭州接種了疫苗，下個月她將去英國讀研究生。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“Because my situation is pretty urgent and all the students around me going abroad have taken it, I feel it’s relatively reliable,” Ms. Zhang said.</div></div><div class="col-lg-6"><div class="article-paragraph">「但是因為我的情況比較急，還有就是我身邊的留學生基本上都打了，我就感覺還是比較可靠的，」艾琳·張說。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Even before this current campaign, more than one million people had <a href="https://www.nytimes.com/2020/11/17/business/china-coronavirus-vaccine-safety.html">lined up to get vaccinated</a>, bewildering scientists who have warned that taking unproven vaccines poses potential health risks. Their efforts now, which are wider in scope, are being rolled out in a similarly ad hoc fashion.</div></div><div class="col-lg-6"><div class="article-paragraph">即便在這次行動之前，就已經有超過100萬人在<a href="#https://cn.nytimes.com/china/20201118/china-coronavirus-vaccine-safety/">排隊接種疫苗</a>，這讓科學家感到困惑，他們警告稱，接種未證明有效的疫苗會帶來潛在的健康風險。如今他們接種疫苗的努力正在以類似的特定方式展開，覆蓋範圍更廣。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">In southern Guangdong Province, 180,000 people — mostly workers involved in food storage and transportation, quarantine facilities and border inspection — had been inoculated as of Dec. 22. In the eastern province of Zhejiang, 281,800 people had been vaccinated. In Wuhan, where the coronavirus was first detected, the government said it had designated 48 vaccination clinics for its emergency program, which started on Thursday.</div></div><div class="col-lg-6"><div class="article-paragraph">截至12月22日，南部省份廣東已有18萬人接種疫苗，其中大多數人都在食品儲存和運輸行業、檢疫設施以及邊境檢查工作。在東部省份浙江，有28.18萬人已經接種了疫苗。在首次發現疫情的武漢，政府表示已經為週四開始的緊急計劃指定了48家疫苗門診。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The United States and Britain only started inoculations after reviewing and approving final-stage trial data that shows the efficacy of these vaccines. By contrast, China, which has five vaccines in Phase 3 trials, has provided little information before moving ahead with its campaign.</div></div><div class="col-lg-6"><div class="article-paragraph">美國和英國是在審查和批准此類後期試驗數據之後，才開始接種疫苗的。相比之下，<a href="https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html">有五種疫苗正在進行三期試驗</a>的中國，在推進其接種行動前，沒有提供多少這些試驗的信息。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Instead, Chinese officials have largely issued broad statements with few details, assuring the public that the vaccines are safe and effective. Three of the vaccines have been approved only for emergency use. Last month, Liu Jingzhen, the chairman of<strong> </strong>Sinopharm, which has two vaccines in late-stage trials, said that none of the roughly one million people vaccinated so far had any adverse reactions and that “only a few had mild symptoms.”</div></div><div class="col-lg-6"><div class="article-paragraph">相反，中國官員發表了細節很少的籠統聲明，僅向公眾保證疫苗安全有效。其中三種疫苗被批准僅用於緊急情況。國藥集團已有兩種疫苗處於後期試驗階段，上個月，其董事長劉敬楨說，到目前為止，接種疫苗的大約100萬人沒有出現任何不良反應，「只有個別的有一些輕微癥狀」。</div></div></div><figure class="article-inline-photo large"><div class="img-box"><img src="../../../../../../static01.nyt.com/images/2020/12/28/business/00china-vaccine-1/00china-vaccine-1-master1050.html" alt="已報告超過9萬病例的巴林批准了輝瑞-BioTech疫苗，以及另一種由中國國藥集團研發的疫苗。" data-src="../../../../../../static01.nyt.com/images/2020/12/28/business/00china-vaccine-1/00china-vaccine-1-master1050.html"></div><figcaption><span>已報告超過9萬病例的巴林批准了輝瑞-BioTech疫苗，以及另一種由中國國藥集團研發的疫苗。</span> <cite>Mazen Mahdi/Agence France-Presse — Getty Images</cite></figcaption></figure><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">On Wednesday, Sinopharm said that one of its vaccine candidates, made by its Beijing Institute of Biological Products arm, had <a rel="noopener noreferrer" target="_blank" href="http://www.bjbpi.com/news_list.asp?id=787">proved to be 79 percent effective</a> in interim Phase 3 trials. Sinopharm said it had applied for Chinese regulatory approval for the vaccine to be used en masse.</div></div><div class="col-lg-6"><div class="article-paragraph">週三，國藥集團表示其旗下北京生物製品研究所生產的一款候選疫苗的<a rel="noopener noreferrer" target="_blank" href="http://www.bjbpi.com/news_list.asp?id=787">三期試驗期中數據有效率達79%</a>。國藥集團表示已向中國監管方申請讓該疫苗投入大規模使用。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The data and approval are expected to come within weeks. While there have been promising signs, they have come with caveats.</div></div><div class="col-lg-6"><div class="article-paragraph">數據和批文預計將於幾週內公布。雖然有令人鼓舞的信號，但也有一些警示。<br></div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-1" data-target="{&quot;pos&quot;:&quot;mid2&quot;,&quot;adv&quot;:&quot;&quot;}"><small>廣告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The United Arab Emirates and Bahrain said this month that <a href="https://www.nytimes.com/2020/12/09/business/china-coronavirus-vaccine-united-arab-emirates.html">a vaccine made by Sinopharm was effective</a>, although they offered few details on how the conclusions were reached. Turkey said a vaccine made by Sinovac, a private Beijing-based vaccine maker, <a href="https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vaccine.html">has an efficacy rate of 91.25 percent,</a> a finding that was based on preliminary results from a small clinical trial. Officials in Brazil said the Sinovac vaccine had an efficacy rate of more than 50 percent but put off releasing detailed data.</div></div><div class="col-lg-6"><div class="article-paragraph">阿拉伯聯合酋長國和巴林本月表示，<a href="#https://cn.nytimes.com/world/20201210/china-coronavirus-vaccine-united-arab-emirates/">國藥集團生產的一種疫苗是有效的</a>，儘管他們沒有提供如何得出該結論的細節。土耳其聲稱，總部位於北京的私營疫苗生產商科興的一種疫苗<a href="https://www.nytimes.com/2020/12/25/health/turkey-brazil-sinovac-coronavirus-vaccine.html">有效率為91.25%</a>，此發現是基於一項小型臨床試驗的初步結果。巴西官員稱科興疫苗的有效率超過50%，但推遲了詳細數據的公布。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The scale and speed of the vaccination drive are the outgrowth of a centralized public health infrastructure in an authoritarian system. During the crisis, China showed how it can mobilize thousands of workers to reach millions of people; it <a href="https://www.nytimes.com/2020/05/26/world/asia/coronavirus-wuhan-tests.html">tested 11 million people</a><strong><a href="https://www.nytimes.com/2020/05/26/world/asia/coronavirus-wuhan-tests.html"> </a></strong><a href="https://www.nytimes.com/2020/05/26/world/asia/coronavirus-wuhan-tests.html">in Wuhan in 10 days.</a></div></div><div class="col-lg-6"><div class="article-paragraph">疫苗接種行動的這種規模和速度是威權體制下公共衛生基礎設施集中化的結果。在危機期間，中國展示了它如何動員成千上萬的工作人員為數以百萬計的民眾提供服務；它在<a href="#https://cn.nytimes.com/china/20200527/coronavirus-wuhan-tests/">10天內檢測了武漢的</a><a href="#https://cn.nytimes.com/china/20200527/coronavirus-wuhan-tests/">1100萬人口</a>。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Chinese vaccine makers have worked to ramp up their production, both for the country’s own needs and for global exports. The Chinese government has promised to produce 610 million doses by the end of the year and expects to make more than one billion doses next year.</div></div><div class="col-lg-6"><div class="article-paragraph">為了滿足本國需求和全球出口，中國疫苗生產商一直在努力提高產量。中國政府承諾到年底生產出6.1億劑疫苗，並預計在明年生產超過10億劑。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“When they say 50 million, they probably will do it,” said Jennifer Huang Bouey, a senior policy researcher at the RAND Corporation and an epidemiologist. “The question is how much it would cost and what is the effect.”</div></div><div class="col-lg-6"><div class="article-paragraph">「他們說要給5000萬人接種，他們就可能做到，」蘭德公司(RAND Corporation)的高級政策研究員、流行病學家黃志環說。「問題在於要花多少錢，效果如何。」</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The all-out effort has taken months of preparation. Since June, hospitals in Guangdong Province have started construction on vaccination clinics, equipped them with refrigerators and installed refrigerated storage systems.</div></div><div class="col-lg-6"><div class="article-paragraph">全力以赴的行動經歷了數月的準備。自6月以來，廣東省的醫院就開始建設疫苗門診，為其配備冷櫃並安裝冷凍儲存系統。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Sinopharm conducted drills this month. In the trial run, workers loaded boxes with the vaccines and ice packs, while company official tracked the vaccines’ temperature in real time during shipment.</div></div><div class="col-lg-6"><div class="article-paragraph">國藥集團於本月進行了演習。在操作測試中，工作人員將放有疫苗和冰袋的箱子裝車，公司管理人員在運輸過程中實時監測疫苗的溫度。</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-2" data-target="{&quot;pos&quot;:&quot;mid3&quot;,&quot;adv&quot;:&quot;&quot;}"><small>廣告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">China has some advantages in its rollout. Unlike the Pfizer vaccine, those made by Sinopharm and Sinovac are based on traditional methods that use inactivated or weakened forms of the virus, making them easier to store and distribute.</div></div><div class="col-lg-6"><div class="article-paragraph">中國在疫苗推廣方面具有一些優勢。與輝瑞(Pfizer)疫苗不同，國藥集團和科興生產的疫苗是基於傳統方法，使用滅活或弱化形式的病毒，使它們更容易儲存和分發。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">But the pitfalls are plenty, as the U.S. experience has shown. In<strong> </strong>the United States, <a href="https://www.nytimes.com/interactive/2020/us/covid-19-vaccine-doses.html">just over two million people</a> have received a Covid-19 vaccine, far short of the 20 million goal the government had set for this month. Hospitals had to prepare the frozen shots and find employees to staff the clinics.</div></div><div class="col-lg-6"><div class="article-paragraph">但正如美國的經驗所顯示的那樣，問題也有很多。在美國，<a href="https://www.nytimes.com/interactive/2020/us/covid-19-vaccine-doses.html">只有200多萬人</a>接種了新冠疫苗，遠低於政府本月設定的2000萬人目標。醫院必須準備好冷凍疫苗，並為門診找到足夠的人手。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">As China has geared up, local officials have been surveying the number of people in the “key priority groups.” They had to “ensure there were no omissions,” according to a government document from Xinchang County in Zhejiang Province.</div></div><div class="col-lg-6"><div class="article-paragraph">在中國進行準備之際，地方官員一直在統計「重點優先人群」的數量。根據浙江省新昌縣的一份政府文件，他們必須「確保沒有遺漏」。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Just two months ago, it appeared that <a href="https://www.nytimes.com/2020/11/17/business/china-coronavirus-vaccine-safety.html">demand could outstrip supply.</a> The eastern city of Yiwu had offered 500 doses, which were used within hours.</div></div><div class="col-lg-6"><div class="article-paragraph">就在兩個月前，疫苗似乎還是<a href="#https://cn.nytimes.com/china/20201118/china-coronavirus-vaccine-safety/">供不應求</a>。東部城市義烏獲得了500劑疫苗，在幾小時內就用光了。</div></div></div><figure class="article-inline-photo large"><div class="img-box"><img src="../../../../../../static01.nyt.com/images/2020/12/28/business/00china-vaccine-2/00china-vaccine-2-master1050.html" alt="12月，在秘魯利馬進行的一項試驗中，志願者正在等待接種國藥集團生產的實驗性疫苗。" data-src="../../../../../../static01.nyt.com/images/2020/12/28/business/00china-vaccine-2/00china-vaccine-2-master1050.html"></div><figcaption><span>12月，在秘魯利馬進行的一項試驗中，志願者正在等待接種國藥集團生產的實驗性疫苗。</span> <cite>Ernesto Benavides/Agence France-Presse — Getty Images</cite></figcaption></figure><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Ms. Zhang, the student, said<strong> </strong>she had initially been hesitant to get a vaccine because everyone around her had told her to “wait and see.” Still, she tried to sign up in Yiwu but failed to secure a spot.</div></div><div class="col-lg-6"><div class="article-paragraph">學生艾琳·張說，她一開始很猶豫要不要接種疫苗，因為身邊所有人都告訴她「等等看」。儘管如此，她還是嘗試在義烏報名接種，但未能獲得名額。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Then, on Dec. 21, Ms. Zhang heard that Hangzhou was going to start its own vaccination drive. She took a high-speed train that night and signed a rental contract with her friend in the city since the local authorities required proof of residence. The next day, she paid $35 and got the shot from Sinovac.</div></div><div class="col-lg-6"><div class="article-paragraph">後來，在12月21日，艾琳·張聽說杭州也將開始自己的疫苗接種行動。由於當地政府要求提供居住證明，她於當晚坐上高鐵抵達，並與在該市的朋友簽訂了租房合約。第二天，她花了220元，接種了科興的疫苗。</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-3" data-target="{&quot;pos&quot;:&quot;mid4&quot;,&quot;adv&quot;:&quot;&quot;}"><small>廣告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">At the hospital, four or five people were waiting to get the vaccine, according to Ms. Zhang. The process took one hour, which included registering, getting the shot and waiting for 30 minutes to see if there were any adverse reactions.</div></div><div class="col-lg-6"><div class="article-paragraph">艾琳·張說，在醫院裡，有四五個人在等著接種疫苗。接種過程花了一小時，包括登記、打針和等待30分鐘，觀察是否有任何不良反應。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“Everything was very calm and orderly,” she said. Before she left, the doctor warned her: Don’t take a shower. Don’t stay up late. Don’t eat foods that could irritate your stomach.</div></div><div class="col-lg-6"><div class="article-paragraph">她說，「整體還是很有平穩、有秩序的。」離開之前，醫生警告她：不要洗澡。不要熬夜。不要吃刺激腸胃的食物。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The government has stressed that the vaccination drive is voluntary, and people will have to pay for the inoculations. Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations and an expert on health care in China, noted that the two-dose regimen could cost about $70, putting it out of reach for the rural poor.</div></div><div class="col-lg-6"><div class="article-paragraph">政府強調稱，疫苗接種行動是自願的，人們必須為接種付費。美國外交關係委員會(Council on Foreign Relations)全球衛生問題高級研究員、中國衛生保健專家黃嚴忠指出，這種兩劑療法的費用大約為70美元，是農村貧困人口無法承受的。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">China could also have problems trying to persuade people to take the vaccine. Scientists warn that the lack of transparency could raise fears about taking a new vaccine, especially in an industry that has <a href="https://www.nytimes.com/2020/12/07/business/china-vaccine-astrazeneca.html">a history of quality scandals.</a></div></div><div class="col-lg-6"><div class="article-paragraph">中國在說服民眾接種疫苗時也可能遇到困難。科學家警告稱，缺乏透明度可能會引發人們對接種新疫苗的擔憂，尤其是在一個有過<a href="../../../../20201207/china-vaccine-astrazeneca/index.html">質量醜聞歷史</a>的行業。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Tao Lina, a vaccine expert and a former immunologist at the Shanghai Center for Disease Control and Prevention, said he knew of several health care workers who had declined the shots. “In the minds of doctors, they feel that any drug that has not passed Phase 3 trials is unreliable,” Mr. Tao said.</div></div><div class="col-lg-6"><div class="article-paragraph">疫苗專家、前上海疾病預防控制中心免疫專家陶黎納指出，他知道有一些醫務工作者拒絕注射疫苗。「因為在醫生的腦海裡面，他覺得沒有通過三期臨床實驗的藥物是不可靠的，」陶黎納說。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Mr. Tao, who got a Sinopharm vaccine on Monday, said he felt confident that the vaccines were safe and effective, echoing officials’ comments that there have been no reports of serious, adverse reactions. But he added that the companies could do better in their messaging.</div></div><div class="col-lg-6"><div class="article-paragraph">陶黎納在週一接種了國藥集團的疫苗，他說相信疫苗是安全有效的，這呼應了官員們的評價，即目前還沒有嚴重的不良反應報告。但他還說，企業可以在信息公開方面做得更好。</div></div></div></div><div class="article-body-aside col-lg-3"></div></div><div class="big_ad" id="medium-rectangle-ad-4" data-target="{&quot;pos&quot;:&quot;mid5&quot;,&quot;adv&quot;:&quot;&quot;}"><small>廣告</small></div><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“If you say that it’s safe, then you should show all kinds of evidence to show that it’s safe,” he said.</div></div><div class="col-lg-6"><div class="article-paragraph">「你既然說它安全，那麼你應該是用各種各樣的證據去證明它的安全，」他說。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Hminem Zhang, a 27-year-old sales employee in an internet company, said he wanted to get a vaccine because he traveled for work and feared a run on the shots if there was a resurgence of the virus. But he worries about the Chinese-made ones because “not many people have received it,” he said.</div></div><div class="col-lg-6"><div class="article-paragraph">27歲的赫米納姆·張（Hminem Zhang，音）是一家互聯網公司的銷售員，他說自己想接種疫苗，因為他經常出差工作，擔心如果病毒再次出現，打疫苗就排不上隊了。但他也擔心國產疫苗的效果，因為「因為畢竟目前還沒有很多人打這個疫苗」，他說。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“I want to wait another month or two for some official data to come out,” said Mr. Zhang, who is based in the southwestern municipality of Chongqing. “And then, if there is no news about any side effects, I will get a shot.”</div></div><div class="col-lg-6"><div class="article-paragraph">「我現在還在觀望，就是想再一兩個月，等待一些官方數據出來，」赫米納姆·張說，他在中國西南的直轄市重慶工作。「然後如果也沒有新聞報導這個疫苗的副作用，我就會去打。」</div></div></div></div><div class="article-body-aside col-lg-3"></div></div></section></div><div class="col-lg-12 row author-info-container"><footer class="author-info"><p>Liu Yi、Amber Wang和Elsie Chen對本文有研究貢獻。</p><p>黃瑞黎(Sui-Lee Wee)是《紐約時報》北京分社記者。她報導中國近十年，關注社會議題、性別、基因監測、醫療保健以及人口和經濟的交叉議題。歡迎在Twitter上關注她 <a rel="nofollow" target="_blank" href="https://twitter.com/suilee">@suilee</a>。</p><p>翻譯：紐約時報中文網</p><p><a rel="nofollow" target="_blank" href="https://www.nytimes.com/2020/12/29/business/china-coronavirus-vaccine.html">點擊查看本文英文版。</a></p></footer></div></article><div class="container article-footer"><div class="row"><div class="col-lg-12 dual-refer-cont"><div class="related-cont"><h4>相關報導</h4><ul class="refer-list"><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20201229/sinovac-covid-19-vaccine/zh-hant/" title="中國科興新冠疫苗的作用原理"><div><h3 class="refer-list-headline">中國科興新冠疫苗的作用原理</h3><p class="refer-pubdate">2020年12月29日</p></div><img alt="中國科興新冠疫苗的作用原理" src="../../../../../../static01.nyt.com/images/2020/12/28/multimedia/c29sinovac-08/c29sinovac-08-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/world/20201210/china-coronavirus-vaccine-united-arab-emirates/zh-hant/" title="中國新冠疫苗在阿聯酋獲正式批准"><div><h3 class="refer-list-headline">中國新冠疫苗在阿聯酋獲正式批准</h3><p class="refer-pubdate">2020年12月10日</p></div><img alt="中國新冠疫苗在阿聯酋獲正式批准" src="../../../../../../static01.nyt.com/images/2021/01/09/business/09china-vaccine01/09china-vaccine01-thumbLarge-v2.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../../20201207/china-vaccine-astrazeneca/zh-hant/index.html" title="中國「疫苗之王」：成功幕布下的醜聞"><div><h3 class="refer-list-headline">中國「疫苗之王」：成功幕布下的醜聞</h3><p class="refer-pubdate">2020年12月7日</p></div><img alt="中國「疫苗之王」：成功幕布下的醜聞" src="../../../../../../static01.nyt.com/images/2020/10/05/business/00china-vaccine-2/00china-vaccine-2-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/china/20201118/china-coronavirus-vaccine-safety/zh-hant/" title="中國新冠疫苗效果未知，但一劑難求"><div><h3 class="refer-list-headline">中國新冠疫苗效果未知，但一劑難求</h3><p class="refer-pubdate">2020年11月18日</p></div><img alt="中國新冠疫苗效果未知，但一劑難求" src="../../../../../../static01.nyt.com/images/2020/11/10/business/00chinavaccine1/merlin_174615984_50ae2e32-a55f-4e9c-8ec7-f2c000c860a2-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../../20200928/china-coronavirus-vaccine/zh-hant/index.html" title="中國豪賭新冠疫苗，數萬人已接種"><div><h3 class="refer-list-headline">中國豪賭新冠疫苗，數萬人已接種</h3><p class="refer-pubdate">2020年9月28日</p></div><img alt="中國豪賭新冠疫苗，數萬人已接種" src="../../../../../../static01.nyt.com/images/2020/09/24/business/00china-vaccines-4/00china-vaccines-4-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../../20200717/china-vaccine-coronavirus/zh-hant/index.html" title="中國在官方監管程序外測試新冠疫苗"><div><h3 class="refer-list-headline">中國在官方監管程序外測試新冠疫苗</h3><p class="refer-pubdate">2020年7月17日</p></div><img alt="中國在官方監管程序外測試新冠疫苗" src="../../../../../../static01.nyt.com/images/2020/07/16/business/00virus-china-vaccine-sub/00virus-china-vaccine-sub-thumbLarge.jpg" width="75" height="75"></a></div></li></ul></div></div><div class="col-lg-12"><div class="related hot_article"><h5 class="related-title">最受歡迎</h5><ol class="related-articles"><li><a href="#https://cn.nytimes.com/opinion/20220127/pakistan-united-states-china/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>「巴鐵」軍方為什麼想與中國保持距離？</h4><img alt="「巴鐵」軍方為什麼想與中國保持距離？" src="../../../../../../static01.nyt.com/images/2022/01/24/opinion/21Rafiq1/21Rafiq1-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220127/computer-chip-shortage-taiwan/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>戰棋推演報告稱台灣半導體工廠停產可能引發中美衝突</h4><img alt="戰棋推演報告稱台灣半導體工廠停產可能引發中美衝突" src="../../../../../../static01.nyt.com/images/2022/01/26/us/politics/26dc-wargames/merlin_177315390_5fcf8532-e370-4f81-8f99-45c6c83044f4-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220126/china-covid-19/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>中國追求「清零」將把國家置於災難之中</h4><img alt="中國追求「清零」將把國家置於災難之中" src="../../../../../../static01.nyt.com/images/2022/01/25/opinion/25emanuel/25emanuel-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/sports/20220127/peng-shuai-china-australian-open/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>澳網再現「彭帥在哪裡」：球員和觀賽者拒絕遺忘、為其發聲</h4><img alt="澳網再現「彭帥在哪裡」：球員和觀賽者拒絕遺忘、為其發聲" src="../../../../../../static01.nyt.com/images/2022/01/26/sports/26aus-china1/merlin_199503951_9c695f25-2b8e-41b4-9c97-bf91de7aa190-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220125/gang-chen-mit-china/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>「我們在殘害我們自己」：華裔教授陳剛案背後的憤怒與幻滅</h4><img alt="「我們在殘害我們自己」：華裔教授陳剛案背後的憤怒與幻滅" src="../../../../../../static01.nyt.com/images/2022/01/24/science/24CHEN-promo/24CHEN-promo-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/virtual-reality-simulation/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>你可以開始相信，我們有可能會活在虛擬現實裡</h4><img alt="你可以開始相信，我們有可能會活在虛擬現實裡" src="../../../../../../static01.nyt.com/images/2022/01/26/opinion/26manjoo-image/26manjoo-image-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/winter-olympics-china-beijing-xi-jinping/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>不再取悅世界：一屆展現習近平全面願景的冬奧會</h4><img alt="不再取悅世界：一屆展現習近平全面願景的冬奧會" src="../../../../../../static01.nyt.com/images/2022/01/13/world/00xi-olympics-30/00xi-olympics-30-thumbLarge.jpg"></article></a></li><li><a href="../../../../20220126/imf-world-economic-report/zh-hant/indexf61c.html?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>國際貨幣基金組織稱中美經濟放緩將拖累全球經濟</h4><img alt="國際貨幣基金組織稱中美經濟放緩將拖累全球經濟" src="../../../../../../static01.nyt.com/images/2022/01/25/multimedia/25global-econ-brf/25global-econ-brf-thumbLarge-v2.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/asia-pacific/20220126/north-korea-launches-missiles-kim/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>朝鮮突然頻繁試射導彈傳遞了什麼信息？</h4><img alt="朝鮮突然頻繁試射導彈傳遞了什麼信息？" src="../../../../../../static01.nyt.com/images/2022/01/21/world/00nkorea-gameplan-01/00nkorea-gameplan-01-thumbLarge.html"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/china-zero-covid-policy/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>多地封鎖引發沮喪與抱怨，中國「清零」政策還能走多遠？</h4><img alt="多地封鎖引發沮喪與抱怨，中國「清零」政策還能走多遠？" src="../../../../../../static01.nyt.com/images/2022/01/20/world/00virus-china-lockdown-01/00virus-china-lockdown-01-thumbLarge.html"></article></a></li></ol></div></div></div></div></div><footer class="row copy-footer">&copy; 2022 The World Economy Observer.<ul class="footerLinkList"><li class="footerLink"><a rel="nofollow" href="/ad/">广告</a></li><li class="footerLink"><a rel="nofollow" href="/about-us/">关于我们</a></li><li class="footerLink"><a rel="nofollow" href="/contact/">联系我们</a></li><li class="footerLink"><a rel="nofollow" href="/tos/">服务条款</a></li><li class="purr-content"></li></ul></footer><script src="../../../../../../d1f1eryiqyjs0r.cloudfront.net/js/libs/require619b.js?v=f1810d8"></script><script src="../../../../../../d1f1eryiqyjs0r.cloudfront.net/js/web/article.min619b.js?v=f1810d8"></script></main></body>
<!-- Mirrored from cn.nytimes.com/business/20201230/china-coronavirus-vaccine/zh-hant/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:11:32 GMT -->
</html>